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a b s t r a c t
AIM: Retroperitoneal soft-tissue sarcomas are relatively uncommon diseases, the most frequent histo-
type, ranging from20% to45%of all cases, is representedby liposarcoma,which is ahard-to treat condition
for its local aggressiveness and clinical aspeciﬁcity.
PRESENTATION OF CASE: We report a case of a 64-years-old woman who underwent surgical resection for
a giant pleomorphic retroperitoneal liposarcoma.
DISCUSSION: Currently chemotherapy for retroperitoneal soft-tissue sarcomas is no effective, and radio-
therapy has limited efﬁcacy due to the toxicity affecting adjacent intra-abdominal structures, showed
validity only in case of high-grade malignancy by reducing local recurrence, but with no advantage in
overall survival. Nowadays only, the complete surgical resection remains the most important predictor
of local recurrence and overall survival.
CONCLUSION: The removal of a retroperitoneal sarcoma of remarkable size is a challenge for the surgeon
owing to the anatomical site, to the absence of an anatomically evident vascular-lymphatic peduncle
and to the adhesions contracted with the contiguous organs and with the great vessels. Therefore, we
believe that, particularly for large-size diseases associated to high-grade malignancy, a complete surgical
resection with removal of the contiguous intra and retroperitoneal organs when inﬁltrated represents
the only therapeutic option to obtain a negative margin and therefore an oncological radicality.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Among the retroperitoneal sarcomas, that represent the 10–15%
of all soft tissue sarcoma [1], the most common histotype is repre-
sented by liposarcoma, which ranges from 20% to 45% of all cases
[2]. It commonly occurs in patients with 40–60 years-old with
a 1:1 ratio between male and female [3]. The liposarcoma may
have weight and dimension variable; those over 20kg are called
“giant liposarcomas” and are extremely rare [3]; some authors
have reported masses between 18 and 46.6 kg [4–6]. We report a
rare case of a giant retroperitoneal liposarcoma even more uncom-
mon for its origin from perirenal fat: infact approximately 13% are
located in the retroperitoneal area, and less than 1/3 of these arise
from perinephric fat [7].
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2. Case report
Wereport a case of a 64year-oldwoman thatwas referred toour
observation for a progressive volumetric increase of the abdomen.
The computed tomography (CT) of the abdomen demonstrated the
presence of a voluminous mass, extending from the sub-hepatic
space up to the pelvic cavity with dislocation of the right kidney
to the left (Figs. 1 and 2). The mass appeared as mixed structure,
characterized by the coexistence of areas with different density,
adipose with thick septa and solid with superﬂuid density, with
cranio–caudal extension of over 30 cm. Therefore the patient was
submitted to an explorative laparotomy which revealed the pres-
ence of a bulky lesion with a multinodular appearance, originating
from the right retroperitoneal region. The lesion had produced a
remarkable dislocation of intra- and retro-peritoneal organs to the
left side dislocating pancreas, kidney and whole intestinal mass
to a space between the left ﬂank and homolateral iliac fossa. For
the apparent inﬁltration of the right kidney (Fig. 3) was performed
a biopsy that conﬁrmed its neoplastic inﬁltration. We proceeded
to release the neoplasm from the adhesions by retroperitoneal
contiguous organs including the vena cava and common iliac ves-
sels, with its subsequent removal en bloc with the right kidney
http://dx.doi.org/10.1016/j.ijscr.2015.02.019
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. CT scan showing the presence of the bulky lesion stretching from the sub-
hepatic region to the pelvic cavity, displacing the right kidney to the left.
Fig. 2. CT scan showing the macroscopic intralesional characteristics, consisting of
the presence of areas with different fat density and thick septa associated with an
inhomogeneous solid component featuring sovraﬂuid-density coarse components.
Fig. 3. Evidence of the close relationship between the lesion and the right kidney
and the origin from the right retroperitoneal region at the level of the ipsilateral
parietocolica space.
(Fig. 4). The postoperative course was uneventful and the patient
was discharged on the 3th postoperative day. The deﬁnitive histo-
logical diagnosis was pleomorphic liposarcoma with myxoid areas,
(42×37×18 cm) (Fig. 5), originating from the right perirenal fat
and inﬁltrating the periureteral tissue, with free resection margin.
At 24 months of follow-up the patient is disease free.
Fig. 4. Right retroperitoneal cavity as it appeared once the lesion had been removed
and the right nephrectomyhadbeenperformed,with evidence of the structures that
had close relations of contiguity with it. The inferior vena cava is easily recognizable
as well as the iliopsoas muscle, gonadal blood vessels and right iliac vessels.
Fig. 5. Picture of the removed surgical specimen including the right kidney.
3. Discussion
The retroperitoneal liposarcomas are generally neoplasms with
a low or intermediate grade of malignancy. The occurrence of
hematogenous metastasis is a rare ﬁnding at the time of diagno-
sis; the lung represents the main site of distant metastases [8].
From a histological point of view, in according to the morphologi-
cal characteristics and on the strength of cytogenetic aberrations,
now widely accepted, we can divide the liposarcoma in 4 types [8]:
(1) undifferentiated, (2) pleomorphic, (3) well differentiated, (4)
myxoid/round cell. The undifferentiated and pleomorphic type are
neoplasm with high grade of malignancy accompanied by remark-
able biological aggressiveness and with metastatic potential while
well-differentiated and myxoid/round cell forms are tumours with
a lowgrade ofmalignancy, associatedwith amore favourable prog-
nosis [9]. The well-differentiated and undifferentiated tumours
represent the most common biological group. The former is char-
acterized by local aggressiveness with low metastatic potential, its
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clinical manifestation occurs through the compression of adjacent
organs or structures, and to the CT imaging usually appears as a
homogeneous lesion with the same density of adipose tissue, well
encapsulated, with the presence of thick septa. Instead, the lat-
ter usually originates from a histological aberration occurring in
the context of a well-differentiated liposarcoma. The further loss
of differentiation determines a cellular transformation, which is
even more characteristic of the relapse of disease, it occurs in 20%
at the ﬁrst recurrence and in 44% at the second one [2]. The CT
imaging of the undifferentiated sarcoma demonstrates a hetero-
geneous, no lipogenic mass [8,10]. In case of diagnostic doubt and
in presence of recurrence, Magnetic Resonance Imaging (MRI) may
be useful because can identifying in a reliable manner the satellite
localizations of the main lesion. The resection of a retroperitoneal
sarcoma of remarkable size is a challenge for the surgeon owing
to the anatomical site, to the absence of an anatomically evident
vascular-lymphatic peduncle thatmakes it hard to obtain safemar-
gin and to the adherences with the contiguous organs and with the
great vessels. Therefore the retroperitoneal liposarcoma shows a
high rate of local recurrence after surgical excision. Actually, the
complete surgical (R0) resection represents the only possibility of
radical treatment, in fact as reported in a study [11] carried out
on 177 patients with retroperitoneal liposarcoma operated with
curative intent, the percentage of patients disease free at 3 and 5
years was 73% and 60% respectively. The prognostic factors sta-
tistically associated with survival were found to be the histotype
and the type of resection performed (complete vs. partial). Actually
the overall survival at 5-years reported in literature for the various
histological subtypeswell differentiated,myxoid/round cell, undif-
ferentiated and pleomorphic, ranging from 90%, 60 to 90%, 75% and
30 to 50%, respectively [11].
The resection of neighbor organs is usually required to facili-
tate dissection, but can be essential to get a radical macroscopic
removal, that signiﬁcantly inﬂuence the prognosis. Neuhaus et al.
[12] reported a study carried out on 190 patients, of whom 72
were submitted to curative surgery for retroperitoneal liposar-
coma (RPLS), and other 47 had undergone palliative resection for
recurrent RPLS. Over half of the patients underwent resection with
curative intention had excision of a contiguous organ to achieve
macroscopic clearance at primary surgery. However, organs were
directly inﬁltrated by tumour in only 4% of patients. However,
as in our patient about the 15% of retroperitoneal liposarcomas
originate from the perirenal fat [7,13]. As in our case report, the
kidneys are often dislocated or rotated by the mass and can be
the site of neoplastic inﬁltration with possible onset of pyelo-
ureteralnephrosis. Consequently they are the organsmost involved
in the resection, immediately followed by the colon [14]. Follow-
ing surgical resection, the 50 - 100% of liposarcomas recur from
residual tissue, which is the primary cause of death [1]. There-
fore an aggressive surgical behaviour is justiﬁed, with the resection
of the structures and viscera adjacent to the pathological process
in the attempt to obtain free disease margin allowing to obtain
a 5-year recurrence rate of 22% that results nevertheless in an
increase morbidity respect to the past [12,15,16]. In fact for this
reason being difﬁcult to discriminate intraoperatively the patho-
logical tissue, from those normal, the tumours should be resected
by including amore abundant quantity of retroperitoneal fat. How-
ever, the resection of organs or structures invaded by the tumour,
although infrequent, should occur only in case in which is not pos-
sible to identify a safe plane of dissection between the tumour and
the organs adjacent to it, with an en bloc resection. Lewis attributes
a peri-operative mortality of 4% identifying haemorrhage, sepsis,
acute myocardial infraction, and multiorganic failure as the princi-
pal causes of death [2]. Actually the chemotherapy treatment used
in theadjuvantorneoadjuvant settinghavenobeneﬁt in the clinical
courseof thediseaseand therefore isnoutilized ina routinemanner
[17]. Doxorubicin only yields a response rate of 18–29%. The antibi-
otic salinomycin, a potassium ionophore, appears to increase the
chemosensitivity to the doxorubicin; so it may be used to decrease
the doxorubicin dosage and its toxic side effects [18]. Neoadju-
vant therapy may be took into account in cases of dedifferentiated
liposarcoma (DDLS), which has an increased risk of recurrence and
metastasis. It’s necessary an accurate subtype-speciﬁc diagnosis to
evaluate the neoadjuvant therapy. In a retrospective study of 120
patients who underwent 137 preoperative percutaneous biopsies
followed by surgical resections, Ikoma [19] has demonstrated that
percutaneous biopsy has lowaccuracy in the diagnosis of retroperi-
toneal DDLS. This can potentially mislead the decision to adopt the
neoadjuvant treatment.
Some retrospective studies have underlined the beneﬁts of the
adjuvant radiotherapy, used in tumours with a diameter greater
than 5 cm and positive surgical margin, with better control of local
recurrence but without increases in long-term survival [20].
4. Conclusion
Our case shows some peculiar characteristics: ﬁrstly its ori-
gin from perirenal fat, infact approximately 13% are located in
the retroperitoneal area, and less than 1/3 of these arise from
perinephric fat; and secondly the huge size (42×37×18 cm) of
liposarcoma, so it can be deﬁned giant.
Actually the surgical approach represents the only therapeutic
option that can provide a concrete perspective of care considering
lackof support of effective complementary therapies. Anaggressive
surgical attitude that includes extended resections of the extra- and
intaperitoneal structures is justiﬁed, especially in tumours of large
size, inorder toobtainamicroscopic radicalityof resectionmargins.
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